HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.30
-0.20 (-0.48%)
Sep 8, 2026, 1:30 PM CST

HeXun Biosciences Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
417.82208.2200.99257.67119.7485.03
Short-Term Investments
411.11301.431727272-
Cash & Short-Term Investments
828.93509.63372.99329.67191.7485.03
Cash Growth
92.89%36.63%13.14%71.94%125.51%-
Accounts Receivable
93.0274.5684.6822.284.98-
Other Receivables
0.270.720.23---
Receivables
93.2975.2884.9122.284.98-
Inventory
9.696.0215.584.6--
Prepaid Expenses
16.49.518.336.859.448.37
Other Current Assets
8.469.181.440.275.080.01
Total Current Assets
956.76609.61483.25363.67211.2493.4
Property, Plant & Equipment
145.27148.22139.1113.9394.27102.83
Other Intangible Assets
17.9620.8826.6734.2641.231.75
Long-Term Deferred Tax Assets
1.31.31.57---
Other Long-Term Assets
57.6157.0756.3459.5757.4196.64
Total Assets
1,179837.07706.92571.43404.15294.62

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.743.174.242.433.232.81
Accrued Expenses
10.7424.7413.19.653.211.42
Current Portion of Long-Term Debt
---2.552.350.59
Current Portion of Leases
3.83.953.042.842.132.07
Current Income Taxes Payable
19.4410.7615.65---
Current Unearned Revenue
7.0213.968.71.733.6-
Other Current Liabilities
32.095.979.0310.985.510.93
Total Current Liabilities
78.8462.5453.7630.1720.037.83
Long-Term Debt
---34.937.2639.41
Long-Term Leases
30.8132.6231.9832.3229.932.03
Long-Term Unearned Revenue
----1.5-
Pension & Post-Retirement Benefits
---0.08--
Long-Term Deferred Tax Liabilities
0.30.3----
Other Long-Term Liabilities
--0.60.60.60.6
Total Liabilities
109.9595.4786.3498.0789.2879.87

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
521.34460460460410360
Additional Paid-In Capital
349.75139.41130.3130.355.3-
Retained Earnings
197.85142.1830.28-116.95-150.44-145.25
Shareholders' Equity
1,069741.6620.58473.36314.87214.75
Total Liabilities & Equity
1,179837.07706.92571.43404.15294.62

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
34.6136.5835.0272.6171.6474.1
Net Cash (Debt)
794.32473.05337.97257.06120.1110.93
Net Cash Growth
100.78%39.97%31.47%114.03%999.17%-
Net Cash Per Share
17.2110.287.345.673.200.36
Filing Date Shares Outstanding
52.134646464630.51
Total Common Shares Outstanding
52.134646464130.51
Working Capital
877.92547.06429.49333.5191.2285.58
Book Value Per Share
20.5016.1213.4910.297.687.04
Tangible Book Value
1,051720.71593.91439.09273.64213.01
Tangible Book Value Per Share
20.1615.6712.919.556.676.98
Machinery
144.61139.67118.9582.4963.5763.23
Leasehold Improvements
34.3131.929.822821.6920.92